Insights from systems pharmacology into cardiovascular drug discovery and therapy.

Background Given the complex nature of cardiovascular disease (CVD), information derived from a systems-level will allow us to fully interrogate features of CVD to better understand disease pathogenesis and to identify new drug targets.